Schematic representation of the artificial neural network developed to predict A) HBsAg seroclearance and B) HBsAg seroconversion.
Ming-Hua Zheng
Wai-Kay Seto
Ke-Qing Shi
Danny Ka-Ho Wong
James Fung
Ivan Fan-Ngai Hung
Daniel Yee-Tak Fong
John Chi-Hang Yuen
Teresa Tong
Ching-Lung Lai
Man-Fung Yuen
10.1371/journal.pone.0099422.g001
https://plos.figshare.com/articles/figure/_Schematic_representation_of_the_artificial_neural_network_developed_to_predict_A_HBsAg_seroclearance_and_B_HBsAg_seroconversion_/1052242
<p>Note: qHBsAg, 3 years before baseline; HBV DNA, 3 years before baseline; qHBsAg reduction, 3 to 2 years before baseline; HBV DNA reduction, 3 to 2 years before baseline.</p>
2014-06-10 03:07:40
Gastroenterology and hepatology
Liver diseases
Infectious hepatitis
Hepatitis B
neural
developed
hbsag
seroclearance